Monteil, Vanessa https://orcid.org/0000-0002-2652-5695
Kwon, Hyesoo https://orcid.org/0000-0003-4637-4609
John, Lijo
Salata, Cristiano https://orcid.org/0000-0002-5136-7406
Jonsson, Gustav https://orcid.org/0000-0001-6692-8395
Vorrink, Sabine U.
Appelberg, Sofia https://orcid.org/0000-0002-7381-3606
Youhanna, Sonia
Dyczynski, Matheus
Leopoldi, Alexandra
Leeb, Nicole
Volz, Jennifer
Hagelkruys, Astrid https://orcid.org/0000-0003-3015-4038
Kellner, Max J.
Devignot, Stéphanie https://orcid.org/0000-0002-0618-5611
Michlits, Georg https://orcid.org/0000-0002-3337-8291
Foong-Sobis, Michelle
Weber, Friedemann https://orcid.org/0000-0001-9737-337X
Lauschke, Volker M. https://orcid.org/0000-0002-1140-6204
Horn, Moritz
Feldmann, Heinz https://orcid.org/0000-0001-9448-8227
Elling, Ulrich https://orcid.org/0000-0002-4514-2809
Penninger, Josef M. https://orcid.org/0000-0002-8194-3777
Mirazimi, Ali https://orcid.org/0000-0003-2371-6055
Funding for this research was provided by:
Vetenskapsrådet (2018-05766)
Article History
Received: 2 March 2023
Accepted: 13 October 2023
First Online: 25 October 2023
Competing interests
: H.F. claims intellectual property of VSV-based filovirus vaccines. All other authors declare no conflicts of interest.